GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (OTCPK:TCNNF) » Definitions » ROE %

Trulieve Cannabis (Trulieve Cannabis) ROE % : -6.58% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Trulieve Cannabis's annualized net income for the quarter that ended in Mar. 2024 was $-92 Mil. Trulieve Cannabis's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was $1,402 Mil. Therefore, Trulieve Cannabis's annualized ROE % for the quarter that ended in Mar. 2024 was -6.58%.

The historical rank and industry rank for Trulieve Cannabis's ROE % or its related term are showing as below:

TCNNF' s ROE % Range Over the Past 10 Years
Min: -31.58   Med: 20.96   Max: Negative Equity
Current: -31.58

During the past 10 years, Trulieve Cannabis's highest ROE % was Negative Equity%. The lowest was -31.58%. And the median was 20.96%.

TCNNF's ROE % is ranked worse than
81.83% of 996 companies
in the Drug Manufacturers industry
Industry Median: 4.225 vs TCNNF: -31.58

Trulieve Cannabis ROE % Historical Data

The historical data trend for Trulieve Cannabis's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis ROE % Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 44.79 21.69 1.39 -12.07 -31.49

Trulieve Cannabis Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.49 -96.81 -6.98 -9.35 -6.58

Competitive Comparison of Trulieve Cannabis's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's ROE % distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's ROE % falls into.



Trulieve Cannabis ROE % Calculation

Trulieve Cannabis's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-526.796/( (1931.16+1414.473)/ 2 )
=-526.796/1672.8165
=-31.49 %

Trulieve Cannabis's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-92.316/( (1414.473+1390.352)/ 2 )
=-92.316/1402.4125
=-6.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


Trulieve Cannabis  (OTCPK:TCNNF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-92.316/1402.4125
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-92.316 / 1190.476)*(1190.476 / 2774.1695)*(2774.1695 / 1402.4125)
=Net Margin %*Asset Turnover*Equity Multiplier
=-7.75 %*0.4291*1.9781
=ROA %*Equity Multiplier
=-3.33 %*1.9781
=-6.58 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-92.316/1402.4125
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-92.316 / 127.784) * (127.784 / 178.96) * (178.96 / 1190.476) * (1190.476 / 2774.1695) * (2774.1695 / 1402.4125)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= -0.7224 * 0.714 * 15.03 % * 0.4291 * 1.9781
=-6.58 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Trulieve Cannabis ROE % Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis (Trulieve Cannabis) Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
Executives
Timothy E Mullany officer: Chief Financial Officer 3551 PLANO PARKWAY, THE COLONY TX 75056
Ryan Blust officer: Chief Financial Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Joy Malivuk officer: Chief Accounting Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Peter Healy director C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Rebecca L. Young officer: Chief Accounting Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kim A. Rivers director, 10 percent owner, officer: Chief Executive Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Thomas L Millner director, 10 percent owner
Thad Beshears director, 10 percent owner C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kyle Landrum officer: Chief Production Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Timothy Morey officer: Chief Sales Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Eric Powers officer: GC and Corporate Secretary C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Susan Thronson director C/O ANGIE'S LIST, INC., 1030 E. WASHINGTON STREET, INDIANPOLIS IN 46202
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Giannella Alvarez director C/O DOMTAR CORPORATION, 234 KINGSLEY PARK DRIVE, FORT MILL SC 29715
Jane C Morreau director